2,826
Views
60
CrossRef citations to date
0
Altmetric
Research Paper

Effects in the use of a genetically engineered strain of Lactococcus lactis delivering in situ IL-10 as a therapy to treat low-grade colon inflammation

, , , , , , , , , , , , , , & show all
Pages 1611-1621 | Received 23 Jan 2014, Accepted 16 Mar 2014, Published online: 14 Apr 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Romina Levit, Naima G. Cortes-Perez, Alejandra de Moreno de Leblanc, Jade Loiseau, Anne Aucouturier, Philippe Langella, Jean Guy LeBlanc & Luis G. Bermúdez-Humarán. (2022) Use of genetically modified lactic acid bacteria and bifidobacteria as live delivery vectors for human and animal health. Gut Microbes 14:1.
Read now
Huan Li, Xinhao Du, Li Yan, Zhenzhen Tang, Ling Zhang, Qiao Zheng, Xianghao Zeng, Guimei Chen, Huawen Yue & Xiangsheng Fu. (2022) Low Abundance of Lactococcus lactis in Human Colorectal Cancer Is Associated with Decreased Natural Killer Cells. Nutrition and Cancer 74:3, pages 938-946.
Read now
Weichun Xie, Liying Song, Xueying Wang, Yigang Xu, Zengsu Liu, Dongfang Zhao, Shubo Wang, Xiaolong Fan, Zhaorui Wang, Chong Gao, Xiaona Wang, Li Wang, Xinyuan Qiao, Han Zhou, Wen Cui, Yanping Jiang, Yijing Li & Lijie Tang. (2021) A bovine lactoferricin-lactoferrampin-encoding Lactobacillus reuteri CO21 regulates the intestinal mucosal immunity and enhances the protection of piglets against enterotoxigenic Escherichia coli K88 challenge. Gut Microbes 13:1.
Read now
. (2014) Landes Highlights. Bioengineered 5:3, pages 149-150.
Read now

Articles from other publishers (56)

Raz Abdulqadir, Jessica Engers & Rana Al-Sadi. (2023) Role of Bifidobacterium in Modulating the Intestinal Epithelial Tight Junction Barrier: Current Knowledge and Perspectives. Current Developments in Nutrition 7:12, pages 102026.
Crossref
Cristina Maria Marginean, Mihaela Popescu, Andrei Ioan Drocas, Sergiu Marian Cazacu, Radu Mitrut, Iulia Cristina Marginean, George Alexandru Iacob, Marian Sorin Popescu, Anca Oana Docea & Paul Mitrut. (2023) Gut–Brain Axis, Microbiota and Probiotics—Current Knowledge on Their Role in Irritable Bowel Syndrome: A Review. Gastrointestinal Disorders 5:4, pages 517-535.
Crossref
Jyoti Sharma, Tuhina Banerjee, Manisha Naithani, Navin Kumar, Sudhir Kumar Singh & Somprakas Basu. 2023. Crohn’s Disease - The Current State of the Art. Crohn’s Disease - The Current State of the Art.
Rocco Mazzolini, Irene Rodríguez-Arce, Laia Fernández-Barat, Carlos Piñero-Lambea, Victoria Garrido, Agustín Rebollada-Merino, Anna Motos, Antoni Torres, Maria Jesús Grilló, Luis Serrano & Maria Lluch-Senar. (2023) Engineered live bacteria suppress Pseudomonas aeruginosa infection in mouse lung and dissolve endotracheal-tube biofilms. Nature Biotechnology 41:8, pages 1089-1098.
Crossref
Tao Zhang, Jindong Zhang & Liping Duan. (2023) The Role of Genetically Engineered Probiotics for Treatment of Inflammatory Bowel Disease: A Systematic Review. Nutrients 15:7, pages 1566.
Crossref
Gabriela Munis Campos, Monique Ferrary Américo, Andria dos Santos Freitas, Fernanda Alvarenga Lima Barroso, Joyce da Cruz Ferraz Dutra, Ludmila Silva Quaresma, Bárbara Fernandes Cordeiro, Juliana Guimarães Laguna, Luís Cláudio Lima de Jesus, Aparecida Maria Fontes, Alexander Birbrair, Tulio Marcos Santos & Vasco Azevedo. (2023) Lactococcus lactis as an Interleukin Delivery System for Prophylaxis and Treatment of Inflammatory and Autoimmune Diseases. Probiotics and Antimicrobial Proteins.
Crossref
Fernanda Alvarenga Lima Barroso, Luís Cláudio Lima de Jesus, Tales Fernando da Silva, Andria dos Santos Freitas, Monique Ferrary Américo, Lucas Jorge da Silva Fernandes, Rafael de Assis Gloria, Gabriela Munis Campos, Rodrigo Dias de Oliveira Carvalho, Túlio Marcos Santos, Juliana Guimarães Laguna & Vasco Ariston de Carvalho Azevedo. 2023. Lactic Acid Bacteria as Cell Factories. Lactic Acid Bacteria as Cell Factories 1 16 .
Meisam Barati, Masoumeh Jabbari, Afshin Abdi Ghavidel, Payman Nikmehr, Pishva Arzhang, Aydin Aynehchi, Mina Babashahi, Erfan Mosharkesh, Neda Roshanravan, Mahdi Shabani & Sayed Hossein Davoodi. (2022) The engineered probiotics for the treatment of chronic diseases: A systematic review. Journal of Food Biochemistry 46:10.
Crossref
Sung-Il Ahn, Sangbuem Cho, Eunjeong Jeon, Myungsun Park, Byungho Chae, Isaac Celestin Poaty DitengouJr.Jr. & Nag-Jin Choi. (2022) The Effect of Probiotics on Intestinal Tight Junction Protein Expression in Animal  Models: A Meta-Analysis. Applied Sciences 12:9, pages 4680.
Crossref
Huan Wang, Jing Wei, Hong Hu, Fuyin Le, Heng Wu, Hong Wei, Jie Luo & Tingtao Chen. (2022) Oral Administration of Bacterial β Cell Expansion Factor A (BefA) Alleviates Diabetes in Mice with Type 1 and Type 2 Diabetes. Oxidative Medicine and Cellular Longevity 2022, pages 1-17.
Crossref
Monique Ferrary Américo, Vasco Azevedo & Rodrigo Dias de Oliveira Carvalho. 2022. Lactic Acid Bacteria in Food Biotechnology. Lactic Acid Bacteria in Food Biotechnology 349 363 .
Nayoun Hong, Seockmo Ku, Kyungjin Yuk, Tony V. Johnston, Geun Eog Ji & Myeong Soo Park. (2021) Production of biologically active human interleukin-10 by Bifidobacterium bifidum BGN4. Microbial Cell Factories 20:1.
Crossref
Tina Vida Plavec, Ana Mitrović, Milica Perišić Nanut, Borut Štrukelj, Janko Kos & Aleš Berlec. (2021) Targeting of fluorescent Lactococcus lactis to colorectal cancer cells through surface display of tumour‐antigen binding proteins . Microbial Biotechnology 14:5, pages 2227-2240.
Crossref
Olga Hartwig, Maryam A. Shetab Boushehri, Karim S. Shalaby, Brigitta Loretz, Alf Lamprecht & Claus-Michael Lehr. (2021) Drug delivery to the inflamed intestinal mucosa – targeting technologies and human cell culture models for better therapies of IBD. Advanced Drug Delivery Reviews 175, pages 113828.
Crossref
Poornima Jeyasekaran & M. Deepa. (2021) FORMULATION OF STIRRED PROBIOTIC FRUIT YOGURT TO BOOST IMMUNITY. Journal of Experimental Biology and Agricultural Sciences 9:Spl-1- GCSGD_2020, pages S169-S175.
Crossref
Gargi Dey, Didier Montet & Phillippe Thonart. 2021. Probiotic Beverages. Probiotic Beverages 309 337 .
Mohamed Tausif Siddiqui & Gail A.M. Cresci. (2020) Microbiota reprogramming for treatment of alcohol-related liver disease. Translational Research 226, pages 26-38.
Crossref
Laísa M. Tavares, Luís C. L. de Jesus, Tales F. da Silva, Fernanda A. L. Barroso, Viviane L. Batista, Nina D. Coelho-Rocha, Vasco Azevedo, Mariana M. Drumond & Pamela Mancha-Agresti. (2020) Novel Strategies for Efficient Production and Delivery of Live Biotherapeutics and Biotechnological Uses of Lactococcus lactis: The Lactic Acid Bacterium Model. Frontiers in Bioengineering and Biotechnology 8.
Crossref
Todd C. Chappell & Nikhil U. Nair. (2020) Engineered lactobacilli display anti-biofilm and growth suppressing activities against Pseudomonas aeruginosa. npj Biofilms and Microbiomes 6:1.
Crossref
Carmen Parisio, Elena Lucarini, Laura Micheli, Alessandra Toti, Mohamad Khatib, Nadia Mulinacci, Laura Calosi, Daniele Bani, Lorenzo Di Cesare Mannelli & Carla Ghelardini. (2020) Pomegranate Mesocarp against Colitis-Induced Visceral Pain in Rats: Effects of a Decoction and Its Fractions. International Journal of Molecular Sciences 21:12, pages 4304.
Crossref
Prasad Minakshi, Rajesh Kumar, Mayukh Ghosh, Basanti Brar, Manju Barnela & Preeti Lakhani. (2020) Application of Polymeric Nano-Materials in Management of Inflammatory Bowel Disease. Current Topics in Medicinal Chemistry 20:11, pages 982-1008.
Crossref
Swastik Sen & Thomas J. Mansell. (2020) Yeasts as probiotics: Mechanisms, outcomes, and future potential. Fungal Genetics and Biology 137, pages 103333.
Crossref
Asma Kazemi, Sepideh Soltani, Sima Ghorabi, Abbas Keshtkar, Elnaz Daneshzad, Fatemeh Nasri & Seyed Mohammad Mazloomi. (2020) Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials. Clinical Nutrition 39:3, pages 789-819.
Crossref
Elaheh Davarpanah, Negar Seyed, Fariborz Bahrami, Sima Rafati, Reza Safaralizadeh & Tahereh Taheri. (2020) Lactococcus lactis expressing sand fly PpSP15 salivary protein confers long-term protection against Leishmania major in BALB/c mice. PLOS Neglected Tropical Diseases 14:1, pages e0007939.
Crossref
Maite Casado-Bedmar & Åsa V. Keita. (2020) Potential neuro-immune therapeutic targets in irritable bowel syndrome. Therapeutic Advances in Gastroenterology 13, pages 175628482091063.
Crossref
Monika Yadav & Pratyoosh Shukla. (2019) Recent systems biology approaches for probiotics use in health aspects: a review. 3 Biotech 9:12.
Crossref
Natalia M. Breyner, Priscilla Bagano Vilas Boas, Gabriel Fernandes, Rodrigo D. de Carvalho, Tatiana Rochat, Marie‐Laure Michel, Florian Chain, Harry Sokol, Marcela de Azevedo, Anderson Myioshi, Vasco A. Azevedo, Philippe Langella, Luis G. Bermúdez‐Humarán & Jean‐Marc Chatel. (2019) Oral delivery of pancreatitis‐associated protein by Lactococcus lactis displays protective effects in dinitro‐benzenesulfonic‐acid‐induced colitis model and is able to modulate the composition of the microbiota . Environmental Microbiology 21:11, pages 4020-4031.
Crossref
Srijita Sireswar, Ishita Ghosh & Gargi Dey. (2019) First and second generation probiotic therapeutics for Inflammatory Bowel Disease. PharmaNutrition 9, pages 100159.
Crossref
Liying Song, Weichun Xie, Zhihang Liu, Dian Guo, Dongfang Zhao, Xinyuan Qiao, Li Wang, Han Zhou, Wen Cui, Yanping Jiang, Yijing Li, Yigang Xu & Lijie Tang. (2019) Oral delivery of a Lactococcus lactis strain secreting bovine lactoferricin–lactoferrampin alleviates the development of acute colitis in mice. Applied Microbiology and Biotechnology 103:15, pages 6169-6186.
Crossref
Jin Cao, Jin Cheng, Siyu Xi, Xueyong Qi, Song Shen & Yanru Ge. (2019) Alginate/chitosan microcapsules for in-situ delivery of the protein, interleukin-1 receptor antagonist (IL-1Ra), for the treatment of dextran sulfate sodium (DSS)-induced colitis in a mouse model. European Journal of Pharmaceutics and Biopharmaceutics 137, pages 112-121.
Crossref
Xiaoting Wang, Kit Wong, Wenjun Ouyang & Sascha Rutz. (2019) Targeting IL-10 Family Cytokines for the Treatment of Human Diseases. Cold Spring Harbor Perspectives in Biology 11:2, pages a028548.
Crossref
Aurélie Mauras, Florian Chain, Aurélie Faucheux, Pauline Ruffié, Sophie Gontier, Bernhard Ryffel, Marie-José Butel, Philippe Langella, Luis G. Bermúdez-Humarán & Anne-Judith Waligora-Dupriet. (2018) A New Bifidobacteria Expression SysTem (BEST) to Produce and Deliver Interleukin-10 in Bifidobacterium bifidum. Frontiers in Microbiology 9.
Crossref
Katarzyna Ciaćma, Jerzy Więckiewicz, Sylwia Kędracka-Krok, Magdalena Kurtyka, Małgorzata Stec, Maciej Siedlar & Jarek Baran. (2018) Secretion of tumoricidal human tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) by recombinant Lactococcus lactis: optimization of in vitro synthesis conditions. Microbial Cell Factories 17:1.
Crossref
Hanis Faudzi, Habibah Faroque, Suet-Lin Chia, Raha Abdul Rahim & Sarah Othman. (2018) Lactococcus lactis: LAB model organism for bacteria-mediated therapeutic strategies. Asia Pacific Journal of Molecular Biology and Biotechnology, pages 1-10.
Crossref
Hui Lee, Haosheng Shen, In Hwang, Hua Ling, Wen Yew, Yung Lee & Matthew Chang. (2018) Targeted Approaches for In Situ Gut Microbiome Manipulation. Genes 9:7, pages 351.
Crossref
Ștefan-Sorin Aramă. (2018) Irritable bowel syndrome and probiotics place in therapeutic strategies. Infectio.ro 56 (4):1, pages 9-21.
Crossref
Dana P. Cook, Conny Gysemans & Chantal Mathieu. (2018) Lactococcus lactis As a Versatile Vehicle for Tolerogenic Immunotherapy. Frontiers in Immunology 8.
Crossref
Ortansa Csutak & Ionela Sarbu. 2018. Genetically Engineered Foods. Genetically Engineered Foods 143 175 .
Yasutomi Higashikuni, William CW Chen & Timothy K Lu. (2017) Advancing therapeutic applications of synthetic gene circuits. Current Opinion in Biotechnology 47, pages 133-141.
Crossref
Rebeca Martín, Florian Chain, Sylvie Miquel, Jean-Paul Motta, Nathalie Vergnolle, Harry Sokol & Philippe Langella. (2017) Using murine colitis models to analyze probiotics–host interactions. FEMS Microbiology Reviews 41:Supp_1, pages S49-S70.
Crossref
Sunil Kumar, Ratnakar Shukla, Prabhat Ranjan & Awanish Kumar. (2017) Interleukin-10: A Compelling Therapeutic Target in Patients With Irritable Bowel Syndrome. Clinical Therapeutics 39:3, pages 632-643.
Crossref
Babasola Sola-OladokunEamonn P. CulliganRoy D. Sleator. (2017) Engineered Probiotics: Applications and Biological Containment. Annual Review of Food Science and Technology 8:1, pages 353-370.
Crossref
Silvina del Carmen, Alejandra de Moreno de LeBlanc, Romina Levit, Vasco Azevedo, Philippe Langella, Luis G. Bermúdez-Humarán & Jean Guy LeBlanc. (2017) Anti-cancer effect of lactic acid bacteria expressing antioxidant enzymes or IL-10 in a colorectal cancer mouse model. International Immunopharmacology 42, pages 122-129.
Crossref
Alejandra de Moreno de LeBlanc, Silvina del Carmen, Jean-Marc Chatel, Vasco Azevedo, Philippe Langella, Luis Bermudez-Humaran & Jean Guy LeBlanc. (2016) Evaluation of the biosafety of recombinant lactic acid bacteria designed to prevent and treat colitis. Journal of Medical Microbiology 65:9, pages 1038-1046.
Crossref
Thibault Allain, Nahla M. Mansour, May M.A. Bahr, Rebeca Martin, Isabelle Florent, Philippe Langella & Luis G. Bermúdez-Humarán. (2016) A new lactobacilli in vivo expression system for the production and delivery of heterologous proteins at mucosal surfaces . FEMS Microbiology Letters 363:13, pages fnw117.
Crossref
Miao Wang, Zeqian Gao, Yongguang Zhang & Li Pan. (2016) Lactic acid bacteria as mucosal delivery vehicles: a realistic therapeutic option. Applied Microbiology and Biotechnology 100:13, pages 5691-5701.
Crossref
M. V. Tejesvi, M. Arvonen, S. M. Kangas, P. L. Keskitalo, A. M. Pirttilä, T. J. Karttunen & P. Vähäsalo. (2015) Faecal microbiome in new-onset juvenile idiopathic arthritis. European Journal of Clinical Microbiology & Infectious Diseases 35:3, pages 363-370.
Crossref
Eleonora Distrutti, Lorenzo Monaldi, Patrizia Ricci & Stefano Fiorucci. (2016) Gut microbiota role in irritable bowel syndrome: New therapeutic strategies. World Journal of Gastroenterology 22:7, pages 2219-2241.
Crossref
Duo-Chen Jin, Hai-Long Cao, Meng-Que Xu, Si-Nan Wang, Yu-Ming Wang, Fang Yan & Bang-Mao Wang. (2016) Regulation of the serotonin transporter in the pathogenesis of irritable bowel syndrome. World Journal of Gastroenterology 22:36, pages 8137.
Crossref
Jayashree Dolpady, Chiara Sorini, Caterina Di Pietro, Ilaria Cosorich, Roberto Ferrarese, Diego Saita, Massimo Clementi, Filippo Canducci & Marika Falcone. (2016) Oral Probiotic VSL#3 Prevents Autoimmune Diabetes by Modulating Microbiota and Promoting Indoleamine 2,3-Dioxygenase-Enriched Tolerogenic Intestinal Environment. Journal of Diabetes Research 2016, pages 1-12.
Crossref
Jean Guy LeBlanc & Alejandra de Moreno de LeBlanc. 2016. Probiotics, Prebiotics, and Synbiotics. Probiotics, Prebiotics, and Synbiotics 755 771 .
Lorena Ruiz, Miguel Gueimonde, Patricia Ruas‐Madiedo, Abelardo Margolles & Borja Sánchez. 2015. Advances in Food Biotechnology. Advances in Food Biotechnology 351 368 .
Elvira M. Hebert, Graciela Savoy de Giori & Fernanda Mozzi. 2015. Biotechnology of Lactic Acid Bacteria. Biotechnology of Lactic Acid Bacteria 297 313 .
Chris P. Verschoor, Avee Naidoo, Jessica G. Wallace, Jennie Johnstone, Mark Loeb, Jonathan L. Bramson & Dawn ME Bowdish. (2014) Circulating Muramyl Dipeptide Is Negatively Associated with Interleukin-10 in the Frail Elderly. Inflammation 38:1, pages 272-277.
Crossref
Alejandra de Moreno de LeBlanc, Silvina del Carmen, Jean-Marc Chatel, Anderson Miyoshi, Vasco Azevedo, Philippe Langella, Luis G. Bermúdez-Humarán & Jean Guy LeBlanc. (2015) Current Review of Genetically Modified Lactic Acid Bacteria for the Prevention and Treatment of Colitis Using Murine Models. Gastroenterology Research and Practice 2015, pages 1-8.
Crossref
Charu Gupta. (2014) Natural Useful Therapeutic Products from Microbes. Journal of Microbiology & Experimentation 1:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.